July 29, 2026- The financial burden of cancer continues to pose a significant challenge for patients and their families across the United States, with many facing staggering costs that can persist throughout treatment and beyond. A new, large study led by researchers at the American Cancer Society (ACS) and the National Cancer Institute finds that cancer-related expenses continue to be high, varying substantially by the type of cancer and how early it is caught. Spending was greatest for patients with advanced cancers, especially at the end-of-life (EOL), topping more than $100K per year. The study is to be published in the Journal of the National Cancer Institute (JNCI).